Antonello Amendola Selected Research

Luteolin

1/2023

A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonello Amendola Research Topics

Disease

5	Infections 04/2024 - 01/2018
3	Colitis 01/2018 - 11/2008
1	Smallpox (Variola) 04/2024
1	Zika Virus Infection 01/2022
1	Dengue (Dengue Fever) 01/2019
1	Ulcerative Colitis 03/2016

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 03/2016 - 11/2008
1	AntibodiesIBA 04/2024
1	Immunoglobulin G (IgG)IBA 04/2024
1	ApigeninIBA 01/2023
1	LuteolinIBA 01/2023
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2019
1	OxazoloneIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 03/2016
1	Sulfonic AcidsIBA 11/2008
1	Ethanol (Ethyl Alcohol)IBA 11/2008
1	AT1002IBA 11/2008
1	Vibrio cholerae zonula occludens toxinIBA 11/2008

Therapy/Procedure

1	Therapeutics 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Off-Label Use 01/2022